BinaxNOW for Evaluating Children for Infection With SARS-CoV-2 (COVID-19)
SARS-CoV2 Infection, COVID-19
About this trial
This is an interventional diagnostic trial for SARS-CoV2 Infection focused on measuring diagnostic, diagnosis, schools, BinaxNOW, surveillance
Eligibility Criteria
Inclusion Criteria:
- Children aged 5 - 15 years inclusive
- Currently attending school K-8 at one of the designated schools of the Madison Metropolitan School District
- Teachers and other school staff aged 20-65 years
Exclusion Criteria:
- Children < 5 years or > 16 years
- Teachers and other school staff < 20 years or > 65 years
Sites / Locations
- University of Wisconsin
Arms of the Study
Arm 1
Experimental
BinaxNOW Surveillance
Participants will agree to the performance of nasal swabs samples to be used for diagnosis or screening. Samples will be obtained by research staff in the school setting. Madison Metropolitan School District (MMSD) has obtained a Clinical Laboratory Improvement Amendments (CLIA) waiver for collection of samples. When there is a positive test, a saliva sample will be collected for testing with a standard polymerase chain reaction (PCR) method. The standard PCR samples will be processed at University of Wisconsin (UW) Clinical Laboratory.